CTMXCytomX Therapeutics, Inc.
$2.19-48% 1Y
$2.19
$2.1252 weeks$6.75
Debt and balance sheet
Can CTMX take a bad year?
The deepest fall in CTMX's price history on file is −99%; it is 68% below its high today.
-2.58
Altman Z-score · Altman's lines at 1.1 and 2.6 · below the 1.1 line in Altman's model
- Cash runway
- 5+ years
Cash runway · burning $13M a quarter at the current rate
- Annualised volatility
- 129%
Annualised volatility · S&P 500 17% · 7.6 times the S&P 500's own swing
- Worst drawdown on file
- −99%
Worst drawdown on file · −68% today
Details›
- Cash and short-term investments
- $348M
- EBITDA, trailing twelve months
- −$94M
- Operating profit, trailing twelve months
- −$95M
- Annualised volatilitytwo years of daily moves
- 129%
- Worst drawdown on file
- −99%
- Below its 52-week high
- 68%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.
Debt and solvency
What it owes against what it owns, and the Altman Z″ score built from it.
How far it has fallen
How much the price moves, how deep and how long its falls have run, and the return per unit of volatility.
Biotechnology
The closest names by size in the same industry